Colorectal Neoplasms: all 5,734 studies

Page 57 of 58. Open to participants first (1,481), then studies with results posted, then the rest; newest registration first within each.

• BMS-247550 in Treating Patients With Metastatic Colorectal CancerTerminatedNCT00033306Phase 2
• Long-term Follow-up Study Designed to Evaluate the Relative Risk of Two Colonoscopy Schedules for Patients With Small PolypsCompletedNCT00032344Phase 3
• Rofecoxib After Surgery in Treating Patients With Stage II or Stage III Colorectal CancerCompletedNCT00031863Phase 3
• NB1011 in Treating Patients With Metastatic or Recurrent Colorectal CancerStatus unknownNCT00031616Phase 1/2
• Combination Chemotherapy in Treating Patients With Advanced or Metastatic Colorectal CancerCompletedNCT00030797Phase 2
• Surgery With or Without Radiofrequency Ablation Followed by Irinotecan in Treating Patients With Colorectal Cancer That is Metastatic to the LiverCompletedNCT00030563Phase 2
• ZD 1839 in Treating Patients With Locally Advanced or Metastatic Colorectal CancerCompletedNCT00030524Phase 2
• Biological Therapy and Chemotherapy in Treating Patients With Metastatic Kidney Cancer or Colorectal CancerCompletedNCT00030342Phase 1/2
• Portal Vein Embolization in Treating Patients With Liver Metastases From Primary Colorectal CancerCompletedNCT00028626Phase 2
• Photodynamic Therapy System for Patients With Refractory/Unresponsive Solid TumorsCompletedNCT00028405Phase 1
• SarCNU in Treating Patients With Recurrent or Metastatic Colorectal CancerCompletedNCT00028015Phase 2
• Vaccine Therapy and Chemotherapy With or Without Tetanus Toxoid Compared With Chemotherapy Alone in Treating Patients With Metastatic Colorectal CancerStatus unknownNCT00027833Phase 2
• Monoclonal Antibody Therapy in Treating Patients With Advanced Colorectal CancerCompletedNCT00027729Phase 1/2
• Curcumin for the Prevention of Colon CancerCompletedNCT00027495Phase 1
• ZD 1839 Plus Combination Chemotherapy in Treating Patients With Locally Advanced, Locally Recurrent, or Metastatic Colorectal CancerCompletedNCT00026364Phase 1
• Oxaliplatin With or Without Gefitinib in Treating Patients With Metastatic or Locally Recurrent Colorectal CancerCompletedNCT00026299Phase 1/2
• Fluorouracil and Leucovorin With or Without Irinotecan in Treating Patients Following Surgery for Stage III Colorectal CancerCompletedNCT00026273Phase 3
• Gefitinib in Treating Patients With Recurrent Metastatic Colorectal CancerCompletedNCT00025350Phase 2
• Gefitinib and Combination Chemotherapy in Treating Patients With Advanced Solid Tumors or Colorectal CancerCompletedNCT00025142Phase 2
• Screening Tests in Detecting Colorectal CancerCompletedNCT00025025
• DHA-Paclitaxel in Treating Patients With Metastatic Colorectal CancerStatus unknownNCT00024401Phase 2
• Combination Chemotherapy With or Without Chemoembolization in Treating Patients With Colorectal Cancer Metastatic to the Liver (6655)TerminatedNCT00023868Phase 3
• BMS-247550 in Treating Patients With Recurrent or Metastatic Colorectal CancerCompletedNCT00022477Phase 2
• Combination Chemotherapy With or Without SU5416 in Treating Patients With Metastatic Colorectal CancerStatus unknownNCT00021281Phase 3
• Tocladesine in Treating Patients With Recurrent or Progressive Metastatic Colorectal CancerStatus unknownNCT00021268Phase 1
• Cetuximab in Treating Patients With Stage IV Colorectal CancerCompletedNCT00020930Phase 2
• Cetuximab Plus Combination Chemotherapy in Treating Patients With Stage IV Colorectal CancerCompletedNCT00020917Phase 2
• Chemotherapy With or Without Isolated Hepatic Perfusion With Melphalan in Treating Patients With Colorectal Cancer That Has Spread to the LiverCompletedNCT00020501Phase 3
• Vaccine Therapy in Treating Patients With Metastatic CancerCompletedNCT00020267Phase 1
• Isolated Hepatic Perfusion With Melphalan Followed By Chemotherapy in Treating Patients With Unresectable Colorectal Cancer That is Metastatic to the LiverCompletedNCT00019760Phase 2
• Vaccine Therapy With or Without Interleukin-2 in Treating Patients With Locally Advanced or Metastatic Colorectal CancerCompletedNCT00019591Phase 1/2
• Oxaliplatin in Treating Patients With Recurrent Metastatic Colorectal CancerCompletedNCT00017082Phase 2
• Combination Chemotherapy in Treating Patients With Metastatic Colorectal Cancer Previously Treated With IrinotecanCompletedNCT00016978Phase 2
• Irinotecan or Fluorouracil Plus Leucovorin in Treating Patients With Previously Treated Metastatic Colorectal CancerCompletedNCT00016952Phase 2
• Ro 31-7453 in Treating Patients With Recurrent or Refractory Metastatic Colorectal CancerCompletedNCT00016250Phase 2
• Fluorouracil and Leucovorin With or Without Oxaliplatin in Treating Patients With Recurrent Metastatic Colorectal CancerCompletedNCT00016198Phase 2
• Vaccine Therapy in Treating Patients With Stage II or Stage III Colon Cancer That Has Been Removed During SurgeryCompletedNCT00016133Phase 1/2
• Fluorouracil and Biological Therapy in Treating Patients With Metastatic Kidney or Colorectal CancerStatus unknownNCT00016042Phase 1
• Comparison of Barium Enema, Computed Tomographic Colonography, and Colonoscopy in Detecting Colon CancerTerminatedNCT00016029Not applicable
• Genetic Markers in Patients With Colorectal CancerCompletedNCT00014079
• Low Literacy Intervention for Colorectal Cancer ScreeningCompletedNCT00012922Not applicable
• Irinotecan With or Without Oxaliplatin in Treating Patients With Metastatic Colorectal CancerCompletedNCT00012389Phase 3
• Combination Chemotherapy in Treating Patients With Unresectable Liver Metastases From Colorectal CancerCompletedNCT00008294Phase 1
• Comparison of Three Chemotherapy Regimens in Treating Patients With Metastatic Colorectal CancerStatus unknownNCT00008281Phase 3
• Combination Chemotherapy in Treating Patients With Unresectable Metastatic Colorectal CancerCompletedNCT00008060Phase 3
• Gemcitabine in Treating Patients With Advanced Colorectal CancerCompletedNCT00007943Phase 2
• Monoclonal Antibody Therapy and/or Vaccine Therapy in Treating Patients With Locally Advanced or Metastatic Colorectal CancerStatus unknownNCT00007826Phase 1/2
• The Identification of Prognostic Factors of Late Stage Disease, Particularly Those That Are Modifiable, That Might Explain the Worsened Prognosis With Colorectal Cancer Among Veterans.CompletedNCT00007618
• Combination Chemotherapy Plus Bevacizumab in Treating Patients With Advanced Colorectal CancerCompletedNCT00006786Phase 2
• Surgery With or Without Combination Chemotherapy in Treating Patients With Liver Metastases From Colorectal CancerStatus unknownNCT00006479Phase 3
• Comparing Two Combination Chemotherapy Regimens in Treating Patients With Metastatic Colorectal CancerStatus unknownNCT00006468Phase 3
• Vaccine Therapy Plus QS21 in Treating Patients With Advanced Pancreatic or Colorectal CancerCompletedNCT00006387Phase 1
• Radiation Therapy Plus Chemotherapy Followed by Surgery in Treating Patients With Locally Advanced Cancer of the RectumCompletedNCT00006366Phase 2
• Octreotide in the Prevention of Diarrhea in Patients Receiving Irinotecan for Metastatic Colon CancerTerminatedNCT00006269Phase 3
• Combination Chemotherapy in Treating Patients With Metastatic Colorectal CancerStatus unknownNCT00006115Phase 2
• Fluorouracil With or Without Mitomycin in Treating Patients With Peritoneal CancerStatus unknownNCT00006112Phase 2
• Combination Chemotherapy in Treating Patients With Colorectal CancerCompletedNCT00006103Phase 3
• Combination Chemotherapy in Treating Patients With Colorectal Cancer That Has Spread to the LiverCompletedNCT00006050Phase 2
• Chemotherapy Plus IM-862 in Treating Patients With Metastatic Colorectal CancerTerminatedNCT00006037Phase 2
• Combination Chemotherapy Plus Trastuzumab in Treating Patients With Advanced, Recurrent, or Metastatic Colorectal CancerTerminatedNCT00006015Phase 2
• SU5416 in Treating Patients With Metastatic or Locally Recurrent Colorectal CancerTerminatedNCT00006001Phase 2
• Combination Chemotherapy in Treating Patients With Metastatic Colorectal CancerCompletedNCT00005981Phase 2
• Second-look Surgery With or Without Intraperitoneal Chemotherapy in Treating Patients With Recurrent Colorectal CancerTerminatedNCT00005944Phase 2
• Nitrocamptothecin in Treating Patients With Advanced or Recurrent Colorectal CancerStatus unknownNCT00005877Phase 2
• Chloroquinoxaline Sulfonamide in Treating Patients With Stage IV Colorectal CancerCompletedNCT00005864Phase 2
• S9923 R115777 in Treating Patients With Advanced Colorectal CancerCompletedNCT00005833Phase 2
• Computerized Tomographic Colonography Compared With Standard Diagnostic Procedures in Detecting Colorectal NeoplasiaCompletedNCT00005809Not applicable
• Lymphatic Mapping and Sentinel Lymph Node Biopsy in the Treatment of Colorectal CancerCompletedNCT00005640Not applicable
• Monoclonal Antibody Therapy in Treating Patients With Colorectal CancerCompletedNCT00005616Phase 1
• Leucovorin and Fluorouracil Compared With Observation in Treating Patients With Colorectal Cancer That Has Been Surgically RemovedCompletedNCT00005586Phase 3
• Rebeccamycin Analog in Treating Patients With Metastatic or Locally Recurrent Colorectal CancerCompletedNCT00005085Phase 2
• Cetuximab and Irinotecan in Treating Patients With Advanced Colorectal CancerCompletedNCT00005076Phase 2
• Eniluracil, Fluorouracil, and Oxaliplatin in Treating Patients With Advanced Colorectal CancerCompletedNCT00005050Phase 1/2
• SCH 66336 Before Surgery in Treating Patients With Colorectal Cancer That Has Metastasized to the LiverWithdrawnNCT00005030Phase 1
• Endoscopic Placement of Metal Stent in Patients With Cancer-Related Bowel ObstructionCompletedNCT00004911Phase 1/2
• Fluorouracil and Leucovorin With or Without Irinotecan in Treating Patients With Metastatic Colorectal CancerCompletedNCT00004885Phase 3
• Olimersen and Irinotecan in Treating Patients With Metastatic or Recurrent Colorectal CancerCompletedNCT00004870Phase 1/2
• Fluorouracil-Uracil and Leucovorin in Treating Elderly Patients With Metastatic Colorectal CancerCompletedNCT00004860Phase 2
• Leucovorin and Fluorouracil With or Without SU5416 in Treating Patients With Metastatic Colorectal CancerCompletedNCT00004252Phase 3
• Study of the Results of Education and Counseling for Persons Undergoing Genetic Testing for Hereditary Nonpolyposis Colon CancerCompletedNCT00004210Not applicable
• Eniluracil and Surgery in Treating Patients With Primary or Metastatic Colorectal CancerCompletedNCT00004195Phase 2
• ISIS 2503 in Treating Patients With Metastatic and/or Locally Recurrent Colorectal CancerTerminatedNCT00004193Phase 2
• Capecitabine and Oxaliplatin in Treating Patients With Advanced or Metastatic Colorectal CancerCompletedNCT00004187Phase 1/2
• Radiofrequency Ablation Followed By Hepatic Artery Chemotherapy in Treating Patients With Colorectal Cancer That Has Spread to the LiverCompletedNCT00004142Phase 2
• Combination Chemotherapy in Treating Patients With Advanced Colorectal CancerCompletedNCT00004102Phase 2
• Radiolabeled Monoclonal Antibody Therapy Plus Peripheral Stem Cell Transplantation in Treating Patients With Metastatic or Recurrent Colorectal Cancer or Pancreatic CancerCompletedNCT00004087Phase 1/2
• Monoclonal Antibody F19 in Treating Patients With Advanced or Metastatic CancerCompletedNCT00004042Phase 1
• Irinotecan Followed By Fluorouracil and Leucovorin in Treating Patients With Stage III or Stage IV Colorectal Carcinoma (Cancer), Other Refractory Carcinoma, or Metastatic Adenoma (Cancer) of Unknown Primary OriginCompletedNCT00004005Phase 2
• Monoclonal Antibody Plus Chemotherapy in Treating Patients With Advanced Colorectal Cancer That Overexpresses HER2CompletedNCT00003995Phase 2
• Irinotecan and Cyclosporine in Treating Patients With Metastatic, Advanced or Locally Recurrent Colorectal CancerCompletedNCT00003950Phase 2
• Irinotecan in Treating Patients With Colorectal CancerTerminatedNCT00003843
• Combination Chemotherapy in Treating Patients With Liver Metastases From Colorectal CancerCompletedNCT00003834Phase 2
• Genetic Study in Patients With Stage II or Stage III Colon CancerCompletedNCT00003833
• Irofulven in Treating Patients With Metastatic or Recurrent Colorectal CancerWithdrawnNCT00003786Phase 2
• Floxuridine, Dexamethasone, and Irinotecan After Surgery in Treating Patients With Liver Metastases From Colorectal CancerCompletedNCT00003753Phase 2
• Chemotherapy Plus Radiation Therapy in Treating Patients With Unresectable, Residual, or Recurrent Colorectal CancerCompletedNCT00003704Phase 1
• Genetic Study of Patients and Families With a History of Colorectal CancerCompletedNCT00003648
• Combination Chemotherapy in Treating Patients With Advanced Colorectal CancerCompletedNCT00003594Phase 3
• Irinotecan in Treating Patients With Metastatic Colorectal CancerCompletedNCT00003544Phase 2
• Monoclonal Antibody Therapy Plus Combination Chemotherapy in Treating Patients With Advanced Colorectal CancerCompletedNCT00003543Phase 1

← Colorectal Neoplasms overview